Search

TransMedics Group Inc

Open

SectorGezondheidszorg

93.49 1.47

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

91.07

Max

94.29

Belangrijke statistieken

By Trading Economics

Inkomsten

7.4M

15M

Verkoop

16M

190M

K/W

Sectorgemiddelde

22.948

57.371

EPS

0.44

Winstmarge

7.729

Werknemers

898

EBITDA

-889K

27M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+0.66% upside

Dividenden

By Acuity

Volgende Winsten

28 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

245M

3.1B

Vorige openingsprijs

92.02

Vorige sluitingsprijs

93.49

Nieuwssentiment

By Acuity

100%

0%

326 / 340 Rangschikking in Healthcare

TransMedics Group Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 aug 2026, 23:06 UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

21 aug 2026, 19:36 UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

20 aug 2026, 19:46 UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

19 aug 2026, 23:11 UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

18 aug 2026, 19:16 UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

13 aug 2026, 19:52 UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

12 aug 2026, 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

11 aug 2026, 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

10 aug 2026, 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

7 aug 2026, 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6 aug 2026, 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5 aug 2026, 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4 aug 2026, 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

3 aug 2026, 19:51 UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

30 jul 2026, 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

29 jul 2026, 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

28 jul 2026, 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

27 jul 2026, 15:16 UTC

Social Media
News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

24 jul 2026, 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

22 jul 2026, 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

21 jul 2026, 14:36 UTC

Social Media

Transmedics Group's shares are higher today following the first lung transplant using its OCS warm-perfusion device, enhancing organ preservation and clinical outcomes.

20 jul 2026, 12:26 UTC

Social Media

TransMedics Group Inc shares are higher in pre-market trading amid strong operational growth, with flights exceeding 36 per day and projected revenue of $3 billion by 2032.

Peer Vergelijking

Prijswijziging

TransMedics Group Inc Prognose

Koersdoel

By TipRanks

0.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 94.22 USD  0.66%

Hoogste 122 USD

Laagste 65 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor TransMedics Group Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

7

Buy

4

Hold

0

Sell

Sentiment

By Acuity

326 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat